Catalent

Catalent is a premier global Contract Development and Manufacturing Organization (CDMO), specializing in delivering innovative solutions for the pharmaceutical, biotech, and consumer health industries. With a commitment to improving lives through superior product development, Catalent offers a comprehensive range of services including oral dose development, bioavailability enhancement, and integrated development solutions. Their advanced technologies encompass a variety of delivery formats such as softgels, orally disintegrating tablets, and inhalation systems.

Catalent's capabilities extend to biologics, cell therapy, gene therapy, and they support clinical supply services, offering robust packaging and logistical solutions. Their global network, featuring state-of-the-art facilities across North America, Europe, and Asia, enables them to tailor solutions that meet diverse customer needs. With an unwavering focus on innovation and patient-centric drug delivery, Catalent stands out as a leader in transforming concepts into successful therapies, making them an indispensable partner for those aiming to advance healthcare solutions.